by TractManager | Jan 18, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of EndeavorRx (Akili Interactive Labs Inc.) to improve attention function in children with...
by TractManager | Jan 18, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of laser interstitial thermal therapy (LITT), also known as stereotactic laser ablation (SLA), for the treatment of...
by TractManager | Jan 18, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the Signatera test.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jan 17, 2023 | Emerging Technology Report
Amvuttra (vutrisiran) is an injectable RNA interference (RNAi) therapeutic agent indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Jan 13, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of VivAer (Aerin Medical Inc.) for the treatment of nasal airway obstruction (NAO).If you have a Hayes login, click...
Recent Comments